Are TIPS tops in the treatment of portal hypertension? A review on the use and misuse of transjugular intrahepatic portosystemic shunts

Canadian Journal of Gastroenterology

Volumn 14, Issue SUPPL. D, 2000, Pages

  Sterling, Richard K ^a   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ascites; Portal hypertension; Transjugular intrahepatic portosystemic shunts; Variceal hemorrhage

Indexed keywords

ASCITES; ENDOSCOPY; ESOPHAGUS VARICES; HUMAN; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; REVIEW;

ASCITES; ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; HUMANS; HYPERTENSION, PORTAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;

EID: 0034330039     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/309539     Document Type: Article

References (63)

1. Prandi D, Rueff B, Roche-Sicot J, et al. Life-threatening hemorrhage of the digestive tract in cirrhotic patients. Am J Surg 1976,131:204-9.
2. DeFranchis R, Primignani M. Why do varices bleed? Gastroenterol Clin North Am 1992;21:85-101.
3. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-9.
4. Smith JL, Graham DY. Variceal hemorrhage. A critical evaluation of survival analysis. Gastroenterology 1982;82:968-73.
5. D'Amico G, Morabito A, Pagliaro L. Six week prognostic indicators in upper gastrointestinal hemorrhage in cirrhotics. Front Gastrointest Res 1986;9:247-58.
6. Soderlund C, Ihre T. Endoscopic sclerotherapy vs conservative management of bleeding oesophageal varices. Acta Chir Scand 1985;151:449-56.
7. Barsoum MS,Bolous FI, El-Rooby A, Rizk-Allah MA, Ibrahim AS. Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. Br J Surg 1982;69:76-8.
8. Cello JP, Grendell JH, Crass RA, et al. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med 1984;311:1589-94.
9. Planas R, Quer JC, Boix J, et al. A prospective randomized trial comparing somatostatin to sclerotherapy in the treatment of acute variceal bleeding. Hepatology 1994;20:370-5.
10. Freedman AM, Sanyal AJ, Tisnado J, et al. Complications of transjugular intrahepatic portasystemic shunt (TIPS): A comprehensive review. Radiographics 1993;13:1185-210.
11. The Copenhagen Esophageal varices sclerotherapy project. Sclerotherapy after first variceal hemorrhage in cirrhotics. N Engl J Med 1984;311:1594-600.
12. Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 1997;92:1081-91.
13. Villeneuve JP, Poier-Layrargues G, Duguay L, et al. Emergency portacaval shunt for variceal hemorrhage: a prospective study. Ann Surg 1987;206:48-52.
14. Stein C, Korula J. Variceal bleeding. What are the treatment options? Postgrad Med J 1995;98:143-9.
15. Rikkers L, Gongliang J, Burnett DA, Buchi KM, Cormier RA. Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a randomized trial. Am J Surg 1993;165:27-33.
16. Soutter DI, Langer B, Taylor BR, Greig P. Emergency portasystemic shunting in cirrhotics with bleeding varices: a comparison of portacaval and mesocaval shunts. HPB Surg 1989;1:107-11.
17. Orloff MJ, Bell RH, Hyde PV, Skivolocki WP. Long-term results of emergency portacaval shunt for bleeding esophageal varices in unselected patients with alcoholic cirrhosis. Ann Surg 1980;192:325-39.
18. Rikkers LF, Jin G. Surgical management of acute variceal hemorrhage. World J Surg 1994;18:193-9.
19. LaBerge JM, Ring EJ, Gordon RL, et al. Creation of transjugular intrahepatic portasystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 1993;187:413-20.
20. Rossle M, Haag k, Ochs A, et al. The transjugular portosystemic stent-shunt procedure for variceal hemorrhage. N Engl J Med 1994;330:165-71.
21. Sanyal AJ, Freedman AM, Luketic VA, et al. Transjugular portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111:138-46.
22. Jalan R, John TG, Redhead DN, et al. A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 1995;90:1932-7.
23. Cao S, Monge H, Semba C, et al. Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: a case report. J Pediatr Surg 1997;32:125-7.
24. Chau TN, Patch D, Chan YW, et al. 'Salvage' transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998;114:981-7.
25. Barange K, Rousseau H, Vinel JP. [Intrahepatic porto-systemic shunt in the treatment of hemorrhage in portal hypertension]. Presse Med 1997;26:1162-7.
26. Rubin RA, O'Brien C, Haskal ZJ, et al. Decreased survival following transjugular portosystemic shunting for Child C patients with high Apache II scores. Am J Gastroenterol 1995;90:556-63.
27. Rosemurgy AS, Goode SE, Zwiebel BR, Black TJ, Brady PG. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg 1996;224:378-84.
28. Sanyal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997;126:849-57.
29. Cello JP, Ring EJ, Olcott EW, et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med 1997;126:858-65.
30. Cabrera J, Maynar M, Granados R, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996;110:832-9.
31. Rossle M, Deibert P, Haag K, et al. Randomized trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997;349:1043-9.
32. Sanyal AJ, Freedman AM, Shiffman ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994;20:46-55.
33. Pomier-Layrargues G. TIPS and hepatic encephalopathy. Semin Liver Dis 1996;16:315-20.
34. Sarin SK, Lahoti D, Saxena SP, Murthi NS, Makwane UK. Prevalence, classification and natural history of gastric varices: long-term follow up study in 568 patients with portal hypertension. Hepatology 1992;95:434-40.
35. Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugular intrahepatic portasystemic shunts. Gastroenterology 1997;112:889-98.
36. Sarin SK. Diagnostic issues: portal hypertensive gastropathy and gastric varices. In: DeFranchis R, ed. Portal Hypertension II. Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science, 1996;3:30-55.
37. Runyon B. Refractory ascites. Semin Liver Dis 1993;13:343-51.
38. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122-8.
39. Arroyo V, Gines P, Gerbes P, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996;23:164-76.
40. Quiroga J, Sangro B, Nunez M, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical renal, humoral and hemodynamic parameters. Hepatology 1995;21:986-94.
41. Somberg K, Lake JR, Tomlanovich SJ, et al. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and humoral response and renal function. Hepatology 1995;21:709-16.
42. Wong F, Sniderman K, Liu P, et al. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995;122:816-22.
43. Ferral H, Bjarnson H, Wegryn SA, et al. Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993;189:795-801.
44. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192-7.
45. Martinet JP, Fenyves D, Legault L, et al. Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution. Dig Dis Sci 1997;42:161-6.
46. Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatology 1996;25:135-44.
47. Ochs A, Gerbes AL, Haag K, et al. TIPS and paracentesis for the treatment of refractory ascites (RA): interim analysis of a randomized controlled trial. Hepatology 1995;25:297A. (Abst)
48. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165-71.
49. Wong F, Blendis L. Transjugular intrahepatic portosystemic shunt: is it the ultimate solution for refractory ascites? Hepatology 1995;22:1613-5.
50. Haskal ZJ, Pentecost MJ, Soulen MC, et al. Transjugular intrahepatic portosystemic shunt Stenosis and revision: early and midterm results. Am J Radiol 1994;163:439-44.
51. Theilman L, Sauer R, Roeren T, et al. Acetylsalicylic acid in the prevention of early stenosis and occlusion of transjugular portal-systemic stent shunts: a controlled study. Hepatology 1994;20:592-7.
52. LaBerge JM, Somberg KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995;108:1143-51.
53. Sanyal AJ, Contos MJ, Yager D, Zhu YN, Willey A, Graham MF. Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: characterization of cell phenotype and function. Hepatology 1998;28:22-32.
54. Lind CD, Malisch TW, Chong WK, et al. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 1994;106:1277-83.
55. Chong WK, Malisch TW, Mazer MJ, Lind CD, Worrell JA, Richards WO. Transjugular portosystemic shunt: US assessment with maximum flow velocity. Radiology 1993;189:789-93.
56. Foshager MC, Ferral H, Nazarran GK, Castaneda-Zuniga WR, Letourneau JG. Duplex sonography after transjugular intrahepatic portosystemic shunts (TIPS): normal hemodynamic findings and efficacy in predicting shunt patency and stenosis. Am J Radiol 1995;165:1-7.
57. Owens Ca, Bartolone C, Warner DL, et al. The inaccuracy of duplex ultrasonography in predicting patency of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998;114:975-80.
58. Feldstein VA, Patel MD, LaBerge JM. Transjugular intrahepatic portosystemic shunts: accuracy of Doppler US in determination of patency and dectection of stenosis. Radiology 1996;201:141-7.
59. Rouillard SS, Bass NM, Roberts JP, et al. Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: natural history and predictors of outcome. Ann Intern Med 1998;128:374-7.
60. Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 1996;23:32-9.
61. Stewart C, Fratkin M, Hirsch JI, Sanyal AJ. Effects of transjugular intrahepatic portosystemic shunts (TIPS) on the function of the reticuloendothelial system (RES). Am J Gastroenterol 1997;92:269A. (Abst)
62. Sanyal AJ, Reddy KR. Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998;115:110-5.
63. Shiffman ML, Jeffers L, Hoofnagle JH, Tralka TS. The role of transjugular intrahepatic portosystemic shunt (TIPS) for treatment of portal hypertension and its complications. Hepatology 1995;22:1591-7.